MicroPort Cardio’s Alwide Plus balloon catheter wins CE mark
September 16, 2025
MicroPort CardioFlow said its Alwide Plus balloon catheter has received CE mark approval, clearing the company to market the device in Europe.
MicroPort CardioFlow said its Alwide Plus balloon catheter has received CE mark approval, clearing the company to market the device in Europe.
Roche announced today that it received CE mark for the integration of its Accu-Chek SmartGuide CGM with the mySugr app.
SMITHFIELD, R.I., Sept. 16, 2025 /PRNewswire/ — ALCOR Scientific today announced a breakthrough in erythrocyte sedimentation rate (ESR) testing that solves one of the most persistent challenges facing modern laboratories: limited blood sample stability.
REVIVO™ Dual Summit features a fusion of ablative, sub-ablative and non-ablative energy treatments with increased power and a larger spot size, pushing the limits for superior results and faster recovery.
BETHLEHEM, Pa., Sept. 15, 2025 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Tromethamine Injection in the EXCEL® IV Container 500 mL in the U.S. market. This addition enhances the company’s ability to serve the diverse needs of providers and their patients.
A team of University of Saskatchewan (USask) researchers have identified a pathway to help the human body defend itself against sepsis—a life-threatening condition caused by the body’s inappropriate response to an infection.
In a new study, University of California, Irvine chemical and biomolecular engineering researchers report the creation of biomolecules that can help grow light-sensitive heart muscle cells in the laboratory. The development enables a biotechnology that could deliver light-triggered signals to the heart, improving its function, without requiring genetic modifications or invasive procedures.
MIT CSAIL researchers developed a tool that can model the shape and movements of fetuses in 3D, potentially assisting doctors in finding abnormalities and making diagnoses.
Expanded indication provides patients with knee osteoarthritis with the benefits of Embosphere’s consistent, predictable, and effective clinical results
Novocure (Nasdaq:NVCR) announced today that it received regulatory approval in Japan for its Optune Lua wearable device.